Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Allakos Inc (Allakos), a subsidiary of Concentra Biosciences LLC, is a clinical stage biotechnology company that develops innovative therapeutics which target immunomodulatory receptors for the treatment of allergic, inflammatory and proliferative diseases. The company pipeline products including AK006 which targets chronic spontaneous urticaria (CSU) and lirentelimab (AK002) designed to target Siglec-8 immunomodulatory receptors for the treatment of inflammation diseases. It is partnered with universities and pharmaceutical companies. Allakos is headquartered in San Carlos, California, the US.
Headquarters
United States of America
Address
Suite 500, 825 Industrial Road, San Carlos, California, 94070
Website
www.allakos.com
Telephone
1 650 5975002
No of Employees
61
Industry
Pharmaceuticals and Healthcare
Allakos Inc premium industry data and analytics
Products and Services
| Products |
|---|
| Pipeline Products |
| AK002: |
| Allergic, Inflammatory and Proliferative Diseases |
| XYZ |
| XYZ |
| XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2026 | Ownership Changes | In February, the company was acquired by Concentra Biosciences LLC. |
| 2023 | Plans/Strategy | In November, the company announced its plans to raise up to US$250 million in public offering of common stock. |
| 2022 | Others | In May, the company announced the filing for offering of up to US$250 million shares of common stock. |
Competitor Comparison
| Key Parameters | Allakos Inc | Eli Lilly and Co | Pfizer Inc | AbbVie Inc | AstraZeneca Plc |
|---|---|---|---|---|---|
| Headquarters | United States of America | United States of America | United States of America | United States of America | United Kingdom |
| City | San Carlos | Indianapolis | New York City | North Chicago | Cambridge |
| State/Province | California | Indiana | New York | Illinois | Cambridgeshire |
| No. of Employees | 61 | 50,605 | 75,000 | 57,000 | 96,100 |
| Entity Type | Private | Public | Public | Public | Public |
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Robert Alexander, Ph.D. | Chief Executive Officer; Director | Executive Board | 2017 | 55 |
| Baird Radford | Chief Financial Officer | Senior Management | 2021 | 54 |
| Chin Lee, M.D. | Chief Medical Officer | Senior Management | 2024 | 55 |
| Adam Tomasi, Ph.D. | President | Senior Management | 2019 | 54 |
| Robert E. Andreatta | Director | Non Executive Board | 2018 | 62 |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer